🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrea Luker

National Institutes of Health

ORCID: 0000-0003-3131-8049

Also affiliated with National Institute of Allergy and Infectious Diseases

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Sphingosine-1-Phosphate Receptor 4 links neutrophils and early local inflammation to lymphocyte recruitment into the draining lymph node to facilitate robust germinal center formation”.

Sphingosine-1-Phosphate Receptor 4 links neutrophils and early local inflammation to lymphocyte recruitment into the draining lymph node to facilitate robust germinal center formation

Frontiers in Immunology(2024)10.3389/fimmu.2024.1427509
N/A
0.241DataRank · unranked
4 citations

Abigail M. Wukitch, Joseph M. Kulinski, Sundar Ganesan, Juraj Kabát, Justin Lack +4 more

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

BMC Immunology(2020)10.1186/s12865-020-0337-5
N/A
0DataRank · unranked
41 citations

Laura Graham, Timothy M. Smith, C. Camarena, Matt P. Zellner, Jamie-Jean S. Gilmer +5 more

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

Research Square(2020)10.21203/rs.2.15818/v2
N/A
0DataRank · unranked
1 citations

Laura Graham, Timothy Smith, Carmen Camarena, Matthew Zellner, Jamie-Jean S Gilmer +5 more

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis

Frontiers in Immunology(2023)10.3389/fimmu.2023.1078958
N/A
0DataRank · unranked
2 citations

Guido H. Falduto, Andrea Luker, Yun Bai, Annika Pfeiffer, Justin Lack +3 more